TOXI-LAB INCORPORATED – Trademark Portfolio

Entity Type: 03

TOXI-LAB INCORPORATED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SPEC. The owner is based in IRMINE, CA.

2 GODDYEAR

IRMINE, CA 92718

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TOXI-LAB INCORPORATED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TOXI-LAB INCORPORATED have?

TOXI-LAB INCORPORATED has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.

What trademark classes does TOXI-LAB INCORPORATED file in?

TOXI-LAB INCORPORATED files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are TOXI-LAB INCORPORATED's most well-known trademarks?

TOXI-LAB INCORPORATED's registered trademark portfolio includes well-known marks such as SPEC. These are among 1 currently registered trademark in the portfolio.

What is TOXI-LAB INCORPORATED's trademark registration success rate?

TOXI-LAB INCORPORATED has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.